|Chemical and physical data|
|Molar mass||450.337 g·mol−1|
|3D model (JSmol)|
ZM-182345 is a nonsteroidal progestin that was never marketed. It was derived from structural modification of the nonsteroidal antiandrogen hydroxyflutamide. ZM-182345 was found to be at least as potent as progesterone as a progestogen in animals but to also possess androgenic activity.
|This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by expanding it.|